We have an updated report [Version - 2024] available. Kindly sign up to get the sample of the report.
all report title image
  • Published In : Nov 2022
  • Code : CMI917
  • Pages :160
  • Formats :
      Excel and PDF
  • Industry : Medical Devices

The global syringe market was valued at US$ 14,839.3 Mn in 2021 and is forecast to reach a value of US$ 25,498.0 Mn by 2028 at a CAGR of 8.0% between 2022 and 2028. The global syringe market is experiencing strong growth due to the rise in prevalence/incidence of chronic diseases worldwide and technological advancements in syringes. Moreover, growing geriatric population and increasing awareness among people is expected to boost the growth of the market. However, factors such as availability of alternate drug delivery methods and increasing incidence of needle-stick injuries are expected to hamper growth of the global syringe market.

Global Syringe Market: Regional Insights

Based on geography, the global syringe market is segmented into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.

Among regions, North America is expected to gain highest share in the market over the forecast period owing to the increase in prevalence of chronic diseases and growing geriatric population in the region. For instance, increase in the prevalence of chronic diseases has led to an increase in the use of syringes, especially disposable syringes. According to the U.S. Centers for Disease Control and Prevention (CDC), chronic diseases such as heart disease, cancer, and diabetes are the leading causes of death and disability in the U.S. Six in ten Americans live with at least one chronic disease, like heart disease and stroke, cancer, or diabetes.

Asia Pacific is also expected to witness robust growth in the global syringe market due to the rise in prevalence of chronic diseases and rising adoption of safety syringes in the region. For instance, non-communicable diseases, including cancer, are emerging as major public health problems in India, which in turn is expected to increase demand for syringes in this region. According to the Indian Council for Medical Research (ICMR), the number of people in India suffering from cancer is expected to rise to 29.8 million in 2025 from 26.7 million in 2021.

Figure 1. Global Syringe Market Share (%), by Region, 2021

SYRINGE MARKET

To learn more about this report, request a free sample copy

Global Syringe Market Drivers:

Rise in prevalence/incidence of chronic diseases around the world is expected to augment growth of the global syringe market over the forecast period. For instance, the use of syringes, especially disposable syringes, is increasing with the increase in incidence or prevalence of chronic diseases worldwide. According to the World Health Organization (WHO), cardiovascular diseases account for most NCD (non-communicable disease) deaths, or 17.9 million people annually, followed by cancers (9.3 million), chronic respiratory diseases (4.1 million), and diabetes (2.0 million including kidney disease deaths caused by diabetes).

Technological advancements in syringes are expected to propel the growth of the global syringe market over the forecast period. For instance, in September 2022, Becton, Dickinson and Company (BD) announced the launch of the next-generation glass prefillable syringe (PFS) that sets a new standard in performance for vaccine PFS with new and tightened specifications for processability, cosmetics, contamination, and integrity. Moreover, the BD EffivaxTM Glass Prefillable Syringe has been designed in collaboration with leading pharmaceutical companies to meet the complex and evolving needs of vaccine manufacturing.

Global Syringe Market Opportunities:

Increase in adoption of injectable drugs across the globe is expected to provide significant growth opportunities for players in the global syringe market. For instance, there is an increase in demand for prefilled syringes as they have a high level of accuracy, making them safer to use. In October 2022, Hikma Pharmaceuticals PLC launched Succinylcholine Chloride Injection, USP, in prefilled syringe (PFS) form. The 100mg/5mL PFS has been launched in the United States. Succinylcholine Chloride is a medication used in hospitals for general anesthesia, to facilitate tracheal intubation, and to provide muscle relaxation during surgery or mechanical ventilation.

Growing geriatric population around the world is expected to offer lucrative growth opportunities for players in the global syringe market. For instance, aging increases the risk of chronic diseases, and with the rise in geriatric population, the demand for syringes is also increasing rapidly. As per the Centers for Disease Control and Prevention (CDC), around 85% of older adults have at least one chronic health condition, and 60% have at least two chronic conditions. Moreover, over 70% senior citizens in India have a chronic illness. This in turn is is expected to offer lucrative growth opportunities for players in the market.

Syringe Market Report Coverage

Report Coverage Details
Base Year: 2021 Market Size in 2021: US$ 14,839.3 Mn
Historical Data for: 2017 to 2020 Forecast Period: 2022 to 2028
Forecast Period 2022 to 2028 CAGR: 8.0% 2028 Value Projection: US$ 25,498.0 Mn
Geographies covered:
  • North America: U.S. and Canada
  • Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
  • Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
  • Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
  • Middle East: GCC Countries, Israel, and Rest of Middle East
  • Africa: South Africa, North Africa, and Central Africa
Segments covered:
  • By Usage: Sterilizable/Reusable Syringes, Disposable Syringes, and Prefilled Syringes
  • By Application: Insulin Syringes, Botox, Osteoarthritis, Human Growth Hormone and Other Applications
Companies covered:

Catalent Inc., Smiths Medical Inc., Cardinal Health, Schott, Nipro Corporation, Terumo Corporation, Gerresheimer AG, B. Braun Melsungen AG, Becton, Dickinson and Company, Codan Medizinische Geräte GmbH & Co. KG, and Hindustan Syringes & Medical Devices Limited, among others.

Growth Drivers:
  • Rise in prevalence/incidence of chronic diseases around the world
  • Technological advancements in syringes
Restraints & Challenges:
  • Availability of alternate drug delivery methods
  • Increasing incidence of needle-stick injuries

Global Syringe Market Trends:

The recent trend in the global syringe market is rise in use of prefilled syringes due to increase in prevalence/incidence of chronic disease. Prefilled syringes have the high level of accuracy, which makes them safer to use. Worldwide, the use of injectable drugs has increased due to the rise in prevalence/incidence of chronic disease around the world.  This trend is expected to continue over the forecast period, driving the growth of the global syringe market.

Moreover, outbreak of COVID-19 (global pandemic) has increased the use of disposable syringes across the globe. With the rise in cases of COVID-19 worldwide, the demand for safe and effective COVID-19 vaccine is also increasing with a rapid pace, which in turn has increased the usage of disposable syringes around the world. This trend is also expected to continue during the forecast period, driving the growth of the global syringe market.

Global Syringe Market Restraints:

Availability of alternate drug delivery methods is expected to hamper growth of the global syringe market over the forecast period. For instance, injections are more effective than drugs but there are various alternative drug delivery methods such as nasal, oral, rectal, buccal, sublingual, vaginal, otic route, ocular route, transdermal, cutaneous, and many others. This in turn is expected to hinder growth of the global syringe market.  

Increasing incidence of needle-stick injuries is expected to hamper the growth of the global syringe market during the forecast period. For instance, needle-stick injuries are known to occur frequently in healthcare settings and can be serious. Needle-stick injuries are wounds caused by needles that accidentally puncture the skin. This in turn is restraining the growth of the market.  

Figure 2. Global Syringe Market Share (%), by Usage, 2021

SYRINGE MARKET

To learn more about this report, request a free sample copy

Global Syringe Market Segmentation:

The global syringe market report is segmented into Usage, Application, and Geography.

Based on Usage, the syringe market is segmented into Sterilizable/Reusable Syringes, Disposable Syringes, and Prefilled Syringes. Out of which, Disposable Syringes Segment is expected to dominate the global syringe market over the forecast period and this is attributed to the outbreak of COVID-19 across the globe. Outbreak of COVID-19 (global pandemic) has increased the use of disposable syringes across the globe.

Prefilled Syringes Segment is also expected to witness significant growth in the near future and this is owing to the increase in prevalence of chronic diseases across the globe. Rise in prevalence of chronic diseases has led to an increase in the use of prefilled syringes worldwide.

Based on Application, the market is segmented into Insulin Syringes, Botox, Osteoarthritis, Human Growth Hormone and Other Applications. Out of which, Insulin Syringes Segment is expected to dominate the market over the forecast period and this is attributed to the increase in prevalence of diabetes around the world. Insulin syringes are used for administering the prescribed insulin dose to diabetic patients.

Osteoarthritis Segment is also expected to witness significant growth in the near future and this is due to the rise in prevalence of osteoarthritis worldwide. Osteoarthritis (OA) affects the joints in the shoulder, spine, feet, hand, knees, and hip joints. OA is a classic age-related disorder, and this in turn has increased the use of syringes worldwide.

Global Syringe Market: Key Developments

In January 2022, Owen Mumford Pharmaceutical Services received approval for the UniSafe 1mL safety device for pre-filled syringes as a combination product in Asia.

In June 2021, to support global COVID-19 immunization efforts, Becton, Dickinson and Company (BD) announced that it has received pandemic orders for 2 billion injectable devices in syringes and needles.

In August 2019, Morimoto Pharmaceuticals, based in Japan, launched a new prefilled syringe kit named Morimoto S.A.F.E. Syringe Kit (Smart Accident prevention, Fast & Easy).

Global Syringe Market: Key Companies Insights

The global syringe market is highly competitive. This is attributed to the increase in adoption of injectable drugs, as a result, players in the market are focusing on developing and launching novel products in the market to meet increasing demand.

Some of the key players in the global syringe market are Catalent Inc., Smiths Medical Inc., Cardinal Health, Schott AG, Nipro Corporation, Terumo Corporation, Gerresheimer AG, B. Braun Melsungen AG, Becton, Dickinson and Company, Codan Medizinische Geräte GmbH & Co. KG, and Hindustan Syringes & Medical Devices Limited, among others.

*Definition: A syringe is a medical device used to inject fluid into the body or withdraw fluid from into the body. A syringe is the tube with a plunger that usually connects to a needle. Syringes are extensively used to administer injections, infuse intravenous therapy into the blood, draw/measure liquids, and apply compounds such as glue or lubricant.

 

Frequently Asked Questions

The global syringe market size is estimated to be valued at US$ 16,023.5 Million in 2022 and is expected to exhibit a CAGR of 8.0% between 2022 and 2028.

Rise in prevalence/incidence of chronic diseases around the world and technological advancements in syringes is fueling the growth of the market.

The disposable syringes segment is the leading usage segment in the market.

Availability of alternate drug delivery methods and increasing incidence of needle-stick injuries are major factors restraining growth of the market.

Major players operating in the market are Catalent Inc., Smiths Medical Inc., Cardinal Health, Schott AG, Nipro Corporation, Terumo Corporation, Gerresheimer AG, B. Braun Melsungen AG, Becton, Dickinson and Company, Codan Medizinische Geräte GmbH & Co. KG, and Hindustan Syringes & Medical Devices Limited, among others.

View Our Licence Options

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

Customize Now

Want to Buy a Report but have a Limited Budget?

We help clients to procure the report or sections of the report at their budgeted price. Kindly click on the below to avail

Request Discount
Logo

Reliability and Reputation

ESOMAR
DUNS Registered
Clutch
DMCA Protected

9001:2015

Reliability and Reputation

27001:2022

Reliability and Reputation

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo